These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 34249224)

  • 1. Genome engineering and disease modeling
    Eksi YE; Sanlioglu AD; Akkaya B; Ozturk BE; Sanlioglu S
    World J Stem Cells; 2021 Jun; 13(6):485-502. PubMed ID: 34249224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designed nucleases for targeted genome editing.
    Lee J; Chung JH; Kim HM; Kim DW; Kim H
    Plant Biotechnol J; 2016 Feb; 14(2):448-62. PubMed ID: 26369767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Origins of Programmable Nucleases for Genome Engineering.
    Chandrasegaran S; Carroll D
    J Mol Biol; 2016 Feb; 428(5 Pt B):963-89. PubMed ID: 26506267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [CRISPR/Cas9 technology in disease research and therapy: a review].
    Shi M; Shen Z; Zhang N; Wang L; Yu C; Yang Z
    Sheng Wu Gong Cheng Xue Bao; 2021 Apr; 37(4):1205-1228. PubMed ID: 33973436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basics of genome editing technology and its application in livestock species.
    Petersen B
    Reprod Domest Anim; 2017 Aug; 52 Suppl 3():4-13. PubMed ID: 28815851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9-AAV Mediated Knock-in at NRL Locus in Human Embryonic Stem Cells.
    Ge X; Xi H; Yang F; Zhi X; Fu Y; Chen D; Xu RH; Lin G; Qu J; Zhao J; Gu F
    Mol Ther Nucleic Acids; 2016 Nov; 5(11):e393. PubMed ID: 27898094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene Editing in Clinical Practice: Where are We?
    Mittal RD
    Indian J Clin Biochem; 2019 Jan; 34(1):19-25. PubMed ID: 30728669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precise Genome Modification via Sequence-Specific Nucleases-Mediated Gene Targeting for Crop Improvement.
    Sun Y; Li J; Xia L
    Front Plant Sci; 2016; 7():1928. PubMed ID: 28066481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of Alternative Nucleases in the Age of CRISPR/Cas9.
    Guha TK; Edgell DR
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of genome editing by programmable nucleases to the metabolic engineering of secondary metabolites.
    Leitão AL; Costa MC; Enguita FJ
    J Biotechnol; 2017 Jan; 241():50-60. PubMed ID: 27845165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9: an advanced tool for editing plant genomes.
    Samanta MK; Dey A; Gayen S
    Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A history of genome editing in mammals.
    Fernández A; Josa S; Montoliu L
    Mamm Genome; 2017 Aug; 28(7-8):237-246. PubMed ID: 28589393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Practical Guide to Genome Editing Using Targeted Nuclease Technologies.
    Porter SN; Levine RM; Pruett-Miller SM
    Compr Physiol; 2019 Mar; 9(2):665-714. PubMed ID: 30873595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome editing comes of age.
    Kim JS
    Nat Protoc; 2016 Sep; 11(9):1573-8. PubMed ID: 27490630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered Viruses as Genome Editing Devices.
    Chen X; Gonçalves MA
    Mol Ther; 2016 Mar; 24(3):447-57. PubMed ID: 26336974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome editing with engineered nucleases in plants.
    Osakabe Y; Osakabe K
    Plant Cell Physiol; 2015 Mar; 56(3):389-400. PubMed ID: 25416289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editing the Mouse Genome Using the CRISPR-Cas9 System.
    Williams A; Henao-Mejia J; Flavell RA
    Cold Spring Harb Protoc; 2016 Feb; 2016(2):pdb.top087536. PubMed ID: 26832693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome Editing in Human Pluripotent Stem Cells.
    Carlson-Stevermer J; Saha K
    Methods Mol Biol; 2017; 1590():165-174. PubMed ID: 28353269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9; A robust technology for producing genetically engineered plants.
    Farooq R; Hussain K; Nazir S; Javed MR; Masood N
    Cell Mol Biol (Noisy-le-grand); 2018 Nov; 64(14):31-38. PubMed ID: 30511631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical review on therapeutic approaches of CRISPR-Cas9 in diabetes mellitus.
    Bora J; Dey A; Lyngdoh AR; Dhasmana A; Ranjan A; Kishore S; Rustagi S; Tuli HS; Chauhan A; Rath P; Malik S
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Dec; 396(12):3459-3481. PubMed ID: 37522916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.